Lu Xu1, Tanxin Liu1, Lili Liu1, Xiaoying Yao1, Lu Chen2, Dongsheng Fan2, Siyan Zhan3,4, Shengfeng Wang5. 1. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China. 2. Department of Neurology, Peking University Third Hospital, Beijing, China. 3. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China. siyan-zhan@bjmu.edu.cn. 4. Center for Clinical Epidemiology, Peking University Third Hospital, Beijing, China. siyan-zhan@bjmu.edu.cn. 5. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China. Shengfeng1984@126.com.
Abstract
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a global disease, which adversely affects the life quality of patients and significantly increases the burden of families and society. We aimed to assess the changing incidence, prevalence of ALS around the world. METHODS: We searched Medline, Embase, Web of Science, and Cochrane library to identify articles published until September 9, 2018. Each included study was independently reviewed for methodological quality by two reviewers. We used a random-effects model to summarize individual studies and assessed heterogeneity (I2) with the χ2 test on Cochrane's Q statistic. RESULTS: We identified 124 studies that were eligible for final inclusion, including 110 studies of incidence and 58 studies of prevalence. The overall crude worldwide ALS prevalence and incidence were 4.42 (95% CI 3.92-4.96) per 1,00,000 population and 1.59 (95% CI 1.39-1.81) per 1,00,000 person-years, respectively. ALS prevalence and incidence increased by age until the age of 70-79. Since 1957, incidence has been significantly rising year by year, and this upward trend was weakened after standardization. The longest survival time were in Asia (ranging from 3.74 years in South Asia to 9.23 years in West Asia). CONCLUSIONS: With the aggravation of population aging and the rapid growth of economy, developing regions following the development pattern of the developed regions may suffer rising ALS prevalence and incidence which may increase their disease burden as well. These data highlight the need for research into underlying mechanism and innovations in health-care systems.
BACKGROUND:Amyotrophic lateral sclerosis (ALS) is a global disease, which adversely affects the life quality of patients and significantly increases the burden of families and society. We aimed to assess the changing incidence, prevalence of ALS around the world. METHODS: We searched Medline, Embase, Web of Science, and Cochrane library to identify articles published until September 9, 2018. Each included study was independently reviewed for methodological quality by two reviewers. We used a random-effects model to summarize individual studies and assessed heterogeneity (I2) with the χ2 test on Cochrane's Q statistic. RESULTS: We identified 124 studies that were eligible for final inclusion, including 110 studies of incidence and 58 studies of prevalence. The overall crude worldwide ALS prevalence and incidence were 4.42 (95% CI 3.92-4.96) per 1,00,000 population and 1.59 (95% CI 1.39-1.81) per 1,00,000 person-years, respectively. ALS prevalence and incidence increased by age until the age of 70-79. Since 1957, incidence has been significantly rising year by year, and this upward trend was weakened after standardization. The longest survival time were in Asia (ranging from 3.74 years in South Asia to 9.23 years in West Asia). CONCLUSIONS: With the aggravation of population aging and the rapid growth of economy, developing regions following the development pattern of the developed regions may suffer rising ALS prevalence and incidence which may increase their disease burden as well. These data highlight the need for research into underlying mechanism and innovations in health-care systems.
Authors: Angeline S Andrew; Erik P Pioro; Meifang Li; Xun Shi; Jiang Gui; Elijah W Stommel; Tanya H Butt; Daniel Peipert; Patricia Henegan; Maeve Tischbein; Pamela Cazzolli; John Novak; Adam Quick; K Doug Pugar; Komal Sawlani; Bashar Katirji; Todd A Hayes; D Kevin Horton; Paul Mehta; Walter G Bradley Journal: Neuroepidemiology Date: 2021-04-26 Impact factor: 3.282
Authors: Sophie Hawkins; Seema C Namboori; Ammarah Tariq; Catherine Blaker; Christine Flaxman; Nidhi S Dey; Peter Henley; Andrew Randall; Alessandro Rosa; Lawrence W Stanton; Akshay Bhinge Journal: Stem Cell Reports Date: 2022-06-23 Impact factor: 7.294
Authors: Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman Journal: Lancet Neurol Date: 2022-03-22 Impact factor: 59.935
Authors: Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Iphigenia Kanara; Anastasios N Mavrakis; Julie Pernokas; Mark Pernokas; Carl A Pinkert; Whitney R Powers; Konstantina Sampani; Kosta Steliou; Demetrios G Vavvas; Robert J Zamboni; Krishna Kodukula; Xiaohong Chen Journal: Biores Open Access Date: 2020-03-31